Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients

J Antimicrob Chemother. 2017 Oct 1;72(10):2954-2955. doi: 10.1093/jac/dkx208.

Authors

Affiliations

¹ IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Laboratoire de Virologie, Hôpital Bichat, AP-HP, Paris, France.
² IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, AP-HP, Paris, France.
³ Centre National de Référence du VIH, AP-HP, Paris, France.

PMID: 29091184
DOI: 10.1093/jac/dkx208

No abstract available

Publication types

Letter
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Anti-HIV Agents / pharmacology
Capsid / drug effects*
Cohort Studies
Drug Resistance, Viral / genetics*
HIV Infections / virology*
HIV-1 / drug effects*
HIV-1 / genetics
High-Throughput Nucleotide Sequencing
Humans
Mutation
gag Gene Products, Human Immunodeficiency Virus / genetics*

Substances

Anti-HIV Agents
gag Gene Products, Human Immunodeficiency Virus